• 2295 Citations
  • 9 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Oteh Maskon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Malaysia Medicine & Life Sciences
Echocardiography Engineering & Materials Science
Optical flows Engineering & Materials Science
clopidogrel Medicine & Life Sciences
Acute Coronary Syndrome Medicine & Life Sciences
Motion estimation Engineering & Materials Science
Coronary Angiography Medicine & Life Sciences
Ultrasonics Engineering & Materials Science

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

  • 2295 Citations
  • 9 h-Index
  • 49 Article
  • 22 Conference contribution
  • 1 Letter

Development and validation of heart rate - Incorporated finger photoplethysmography fitness index algorithm for cardiovascular disease risk assessment

Lazim, M. R. M. L. M., Aminuddin, A., Chell, K., Ugusman, A., Salamt, N., Maskon, O., Ahmad, W. A. N. W., Mohamad, M. S. F. & Yusof, A. K. M., 24 Jan 2019, 2018 IEEE EMBS Conference on Biomedical Engineering and Sciences, IECBES 2018 - Proceedings. Institute of Electrical and Electronics Engineers Inc., p. 75-79 5 p. 08626725. (2018 IEEE EMBS Conference on Biomedical Engineering and Sciences, IECBES 2018 - Proceedings).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

heart rate
risk assessment
Risk assessment

Drug Coated Balloon-Only Strategy in de Novo Lesions of Large Coronary Vessels

Rosenberg, M., Waliszewski, M., Krackhardt, F., Chin, K., Wan Ahmad, W. A., Caramanno, G., Milazzo, D., Nuruddin, A. A., Liew, H. B., Maskon, O., Bento, A., MacIa, J. C. & Frey, N., 1 Jan 2019, In : Journal of Interventional Cardiology. 2019, 6548696.

Research output: Contribution to journalArticle

Open Access
Coronary Artery Disease
Coronary Vessels
Pharmaceutical Preparations
Propensity Score

The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

Kim, Y. H., Shim, J., Tsai, C. T., Wang, C. C., Vilela, G., Muengtaweepongsa, S., Kurniawan, M., Maskon, O., Hsu, L. F., Nguyen, T. H., Sim, K. & Camm, A. J., 1 Jun 2019, In : Chest. 155, 6, p. 1309-1311 3 p.

Research output: Contribution to journalLetter

Open Access
Atrial Fibrillation
1 Citation (Scopus)

1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration

MASCOT & REMEDEE Registry Investigators, 8 Oct 2018, In : JACC: Cardiovascular Interventions. 11, 19, p. 1969-1978 10 p.

Research output: Contribution to journalArticle

197 Citations (Scopus)

Alirocumab and cardiovascular outcomes after acute coronary syndrome

ODYSSEY OUTCOMES Committees and Investigators, 29 Nov 2018, In : New England Journal of Medicine. 379, 22, p. 2097-2107 11 p.

Research output: Contribution to journalArticle

Acute Coronary Syndrome
Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Cholesterol